LBRX
LBRX
NASDAQ · Pharmaceuticals

Lb Pharmaceuticals Inc

$24.21
+0.84 (+3.59%)
As of Mar 25, 10:03 PM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target -37.2% upside
Low Target $11.61
Average Target $15.21
High Target $18.52
Current Price $24.21
Current
$24.21
Target
$15.21
$11.61 $15.21 avg $18.52
Scenario Analysis
Bear Case
$11.61
-52.0%
Low target
Base Case
$15.21
-37.2%
Avg target
Bull Case
$18.52
+-23.5%
High target
Risk/Reward
0.5x
Unfavorable
Price in Context
52-Week High
$27.55
-12.1% from high
52-Week Low
$13.36
+81.2% from low
Target vs 52W High
$15.21
-44.8% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%